Clinical Trial

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers
Trial Details
NCT Number NCT07682948
Lead Sponsor Korea United Pharm. Inc.
Conditions Hypertension, Dyslipidemia
Enrollment 36 participants
Start Date 2026-07-01
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-06